AOD-9604 Modified fragment of human growth hormone (hGH 176-191) that has been studied for its ability to stimulate fat metabolism and promote weight reduction without increasing IGF-1 activity
Joe Rogan himself has noted on the podcast that a lot of people are getting bogus peptides
Safety, Regulatory Status, and Who Should Not Use BPC-157 Human safety data for BPC-157 are limited to anecdotal reports and case series, not controlled trials
This first of its kind co-brand card allows members to pay rent and earn points with no transaction fees on rent payments at any apartment in the U.S." "In the first quarter, we selected nCino to streamline our origination, underwriting and portfolio management for our small business customers
The rationale for blending these two peptides stems from their non-overlapping receptor targets and complementary metabolic effects: Amylin Pathway (Cagrilintide): Targets amylin receptors in the brainstem Creates meal-specific satiety signals Slows gastric emptying through distinct mechanisms Reduces meal size and eating frequency Triple Agonist Pathway (Retatrutide): Activates GIP, GLP-1, and glucagon receptors Enhances insulin secretion and glucose metabolism Increases energy expenditure through glucagon effects Provides broader metabolic regulation When combined, these pathways could theoretically provide additive or synergistic effects on weight management and metabolic function